Hardman Johnston Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Hardman Johnston Global Advisors's JAZZ Position: Q2 2026 in Review
Hardman Johnston Global Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 28,817 shares worth $6.94M. The stake represents 0.24% of the portfolio and ranks #47 among its holdings. This is a return to the name: Hardman Johnston Global Advisors previously reported a position in JAZZ as recently as Q1 2020.
Hardman Johnston Global Advisors first reported a position in JAZZ in Q1 2016 and has held it in 18 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Hardman Johnston Global Advisors held 28,817 shares of Jazz Pharmaceuticals worth $6.94M as of Q2 2026.
- Jazz Pharmaceuticals was a new Hardman Johnston Global Advisors position in Q2 2026.
- Jazz Pharmaceuticals made up 0.24% of Hardman Johnston Global Advisors's portfolio in Q2 2026, its #47 holding.
- Hardman Johnston Global Advisors first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 18 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Hardman Johnston Global Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.